HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Boersma Selected Research

xemilofiban

4/2009Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).
11/2008Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Boersma Research Topics

Disease

73Heart Failure
10/2022 - 05/2002
68Myocardial Infarction
01/2022 - 01/2002
57Acute Coronary Syndrome
01/2022 - 01/2002
54Coronary Artery Disease (Coronary Atherosclerosis)
11/2020 - 01/2002
42Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2002
25ST Elevation Myocardial Infarction
01/2021 - 05/2005
23Thrombosis (Thrombus)
08/2017 - 05/2004
20Stroke (Strokes)
05/2022 - 01/2004
17Death (Near-Death Experience)
01/2022 - 05/2007
15Atherosclerotic Plaque (Atheroma)
10/2020 - 03/2014
14Myocardial Ischemia (Ischemic Heart Diseases)
11/2021 - 02/2003
14Infarction (Infarctions)
11/2021 - 06/2002
14Congenital Heart Defects (Congenital Heart Defect)
10/2020 - 06/2008
14Diabetes Mellitus
06/2020 - 04/2002
14Cardiomyopathies (Cardiomyopathy)
12/2019 - 04/2002
13Stable Angina
01/2018 - 05/2005
10Hemorrhage
12/2021 - 01/2002
10Heart Diseases (Heart Disease)
10/2020 - 09/2003
8Coronary Disease (Coronary Heart Disease)
05/2022 - 01/2006
8Atrial Fibrillation
12/2021 - 12/2004
8Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2021 - 01/2003
8Hypertension (High Blood Pressure)
10/2020 - 06/2002
7Cardiac Arrhythmias (Arrythmia)
01/2022 - 07/2009
7Atherosclerosis
10/2018 - 02/2007
7Ischemia
03/2014 - 02/2003
6Renal Insufficiency (Renal Failure)
01/2021 - 09/2005
5Tetralogy of Fallot (Fallot Tetralogy)
01/2022 - 06/2008
5Cardiotoxicity
01/2022 - 09/2011
5Inflammation (Inflammations)
10/2020 - 01/2006
5Pulmonary Hypertension
04/2020 - 04/2015
5Pathologic Constriction (Stenosis)
01/2018 - 05/2007
5Mitral Valve Insufficiency (Mitral Regurgitation)
09/2011 - 05/2005
4Breast Neoplasms (Breast Cancer)
01/2022 - 01/2019
4Type 2 Diabetes Mellitus (MODY)
11/2021 - 02/2006
4Disease Progression
01/2021 - 06/2014
4Aortic Coarctation
10/2020 - 06/2008
4Left Ventricular Dysfunction
12/2019 - 01/2004
4Cardiogenic Shock
01/2017 - 01/2012
4Cicatrix (Scar)
01/2011 - 02/2006
3Pulmonary Arterial Hypertension
01/2022 - 01/2020
3Vascular Diseases (Vascular Disease)
11/2021 - 06/2009
3COVID-19
01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

50Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2006
27omega-Chloroacetophenone (Mace)IBA
01/2022 - 05/2002
22pro-brain natriuretic peptide (1-76)IBA
05/2022 - 05/2006
18Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 05/2006
18Sirolimus (Rapamycin)FDA Link
01/2020 - 05/2005
14Troponin T (Troponin T1)IBA
06/2020 - 01/2006
13Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 12/2005
13DobutamineFDA LinkGeneric
01/2020 - 09/2002
12C-Reactive ProteinIBA
11/2020 - 04/2003
12CalciumIBA
01/2017 - 08/2009
11Glycoproteins (Glycoprotein)IBA
04/2012 - 01/2002
10LipidsIBA
01/2022 - 05/2007
10PerindoprilFDA LinkGeneric
11/2021 - 04/2006
10Glucose (Dextrose)FDA LinkGeneric
11/2021 - 04/2002
10MetalsIBA
10/2018 - 05/2005
10Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2016 - 01/2004
8TroponinIBA
01/2021 - 03/2004
8Platelet Membrane GlycoproteinsIBA
04/2007 - 01/2002
7Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2016 - 11/2007
6CreatinineIBA
01/2021 - 12/2010
6Phenobarbital (Luminal)FDA Link
10/2018 - 03/2011
6Pharmaceutical PreparationsIBA
10/2018 - 01/2002
6Paclitaxel (Taxol)FDA LinkGeneric
01/2015 - 02/2007
6Abciximab (ReoPro)FDA Link
01/2006 - 01/2003
5LDL CholesterolIBA
01/2022 - 05/2007
5Trinitrotoluene (TNT)IBA
06/2020 - 01/2006
5CholesterolIBA
06/2020 - 06/2002
5Galectin 3 (LGALS3)IBA
12/2019 - 12/2013
5zotarolimusIBA
10/2016 - 12/2009
5Tirofiban (Aggrastat)FDA Link
08/2011 - 01/2003
4Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2019
4oxidized low density lipoproteinIBA
01/2022 - 10/2018
4Trastuzumab (Herceptin)FDA Link
01/2022 - 01/2019
4Natriuretic PeptidesIBA
01/2022 - 01/2011
4CytokinesIBA
10/2020 - 04/2003
4LDL Lipoproteins (beta Lipoproteins)IBA
06/2020 - 05/2007
4Eptifibatide (Integrilin)FDA Link
06/2004 - 01/2002
3Vitamin KFDA Link
12/2021 - 07/2015
3AnticoagulantsIBA
12/2021 - 07/2015
3Insulin (Novolin)FDA Link
11/2021 - 04/2002
3Peroxidase (Myeloperoxidase)IBA
01/2021 - 10/2019

Therapy/Procedure

58Percutaneous Coronary Intervention
01/2021 - 06/2002
53Therapeutics
01/2022 - 01/2002
29Stents
01/2020 - 05/2005
20Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2018 - 06/2002
20Cardiac Resynchronization Therapy
11/2011 - 08/2002
17Vascular Surgical Procedures
10/2020 - 04/2003
12Heart Transplantation (Grafting, Heart)
10/2021 - 12/2016
12Drug-Eluting Stents
01/2015 - 06/2005
8Heart-Assist Devices
10/2021 - 01/2017
7Cardiac Rehabilitation
03/2022 - 01/2018
6Secondary Prevention
09/2018 - 04/2003
5Fontan Procedure (Fontan Operation)
01/2021 - 06/2008
5Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
09/2018 - 07/2009
4Thrombolytic Therapy
01/2021 - 03/2004
4Mitral Valve Annuloplasty
09/2011 - 05/2005
4Catheter Ablation
01/2011 - 03/2005
3Electric Countershock (Cardioversion)
01/2022 - 01/2020